Latest news with #Oddity
Yahoo
31-05-2025
- Business
- Yahoo
I asked ChatGPT which stocks in my ISA and SIPP are at risk from AI and it said this…
On several occasions in recent years, Alphabet CEO Sundar Pichai has said: 'AI has the potential to be more transformative than electricity or fire.' I've been spending some time thinking about how AI could either electrify or burn down companies in my ISA/SIPP portfolio. There's evidence emerging that the internet is already shifting from being search-driven to AI-driven. In other words, a zero-click internet is developing, where users get what they need from AI summaries without visiting external websites. This could trigger second- and third-order effects, impacting many internet-based business models. Somewhat fittingly then, I asked ChatGPT to run its artificial intelligence over my portfolio and rank each stock as either low, moderate or high risk of being disrupted by such AI trends. Here's what it said. Let's start with those it reckons are at high risk of disruption. It flagged up language learning app Duolingo (NASDAQ: DUOL), which it said is 'highly reliant on app engagement, gamified learning, and digital visibility.' I'm less worried about Duolingo struggling in a zero-click internet world, as it already enjoys very strong brand awareness on social media. Many of its 130m monthly active users signed up through word of mouth, which the bot doesn't mention. Q1 revenue jumped 38% year on year to $231m, with paid subscribers rising 40% to 10.3m. The company is absolutely thriving. That said, more powerful AI-powered apps could pop up, tempting learners to cancel their paid Duolingo subscriptions. So this is worth monitoring. Another stock it said was vulnerable to AI and zero-click disruption was Oddity Tech. This is a fast-growing direct-to-consumer beauty brand with a strong digital marketing focus. The stock is up 100% since I identified it as a hidden gem around one year ago. ChatGPT said AI voice commerce, where customers tell voice assistants like Alexa to shop online and make purchases, could bypass Oddity's offerings. That's plausible, though I'm reassured that 60% of Oddity's revenue is repeat purchases, indicating high customer satisfaction. A third stock the bot highlighted was e-commerce enabler Shopify. It said its merchants 'depend heavily on SEO [search engine optimisation], paid traffic, and social discovery — all threatened by AI assistants'. I'm not convinced that Shopify is at risk. If anything, it should benefit as it rolls out powerful AI tools for merchants, something it's already doing. The final one was The Trade Desk, which is an ad-tech company that helps advertisers buy programmatic ads. ChatGPT pointed out that it 'thrives on ads shown across the open web – news sites, blogs, websites'. But in a world of fewer clicks and shrinking third-party ad space, The Trade Desk risks losing relevance. I would also add that the company also has a growing connected TV business. Streaming platforms like Netflix and Disney, with whom it's partnered, are not facing changing consumer behaviour. Thankfully, most stocks in my portfolio are at low risk of AI disruption, according to ChatGPT. These include chip maker Taiwan Semiconductor (TSMC), robotics giant Intuitive Surgical, and luxury carmaker Ferrari. None rely on internet clicks. Two others I would highlight are Novo Nordisk and AstraZeneca. These pharma giants should actually benefit from AI-driven drug discovery. While lower US drug prices present a medium-term risk to their profits, I think both are worth considering buying. The post I asked ChatGPT which stocks in my ISA and SIPP are at risk from AI and it said this… appeared first on The Motley Fool UK. More reading 5 Stocks For Trying To Build Wealth After 50 One Top Growth Stock from the Motley Fool Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool's board of directors. Ben McPoland has positions in AstraZeneca Plc, Duolingo, Ferrari, Intuitive Surgical, Novo Nordisk, Oddity Tech, Shopify, Taiwan Semiconductor Manufacturing, and The Trade Desk. The Motley Fool UK has recommended Alphabet, AstraZeneca Plc, Duolingo, Intuitive Surgical, Novo Nordisk, Shopify, Taiwan Semiconductor Manufacturing, and The Trade Desk. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. Motley Fool UK 2025 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
17-05-2025
- Business
- Yahoo
Oddity Tech (NasdaqGM:ODD) Raises Full-Year Earnings Guidance
Oddity Tech recently announced impressive first-quarter earnings and raised its full-year earnings guidance, projecting higher net revenue than previously anticipated. These positive developments likely played a significant role in the company's 56% share price increase over the past month, markedly outperforming the broader market's 5% rise over the same period. Oddity's strengthened financial outlook, with anticipated annual growth surpassing long-term expectations, underscores investor confidence in its potential. This robust performance, coupled with market trends, places Oddity Tech in a favorable position as it exceeds both its own benchmarks and broader economic projections. Every company has risks, and we've spotted 1 possible red flag for Oddity Tech you should know about. Find companies with promising cash flow potential yet trading below their fair value. The recent first-quarter earnings announcement and full-year guidance upgrade for Oddity Tech have had a positive impact on the company's narratives around growth and innovation. These developments highlight the potential for increased revenue through strategic international expansion and the upcoming launch of Brand 3 aimed at high-margin sales. This aligns with the company's focus on tech-driven customization and product development, which is expected to enhance customer experience and support future earnings growth. Long-term performance for Oddity Tech's shares has been strong, with a total return of 48.69% over the past year, substantially higher than the US Personal Products industry, which experienced a decline. This robust return underscores the market's confidence in Oddity Tech's ability to outperform its sector amid challenging conditions. Additionally, the company's earnings growth over the past year has far exceeded industry averages, supporting the view that it is well-positioned in its market. Despite the impressive share price increase of 56% in the past month due to recent developments, the current share price of US$47.13 remains below the consensus analyst price target of US$53.44. This suggests there may still be room for appreciation if Oddity Tech achieves its ambitious revenue and earnings forecasts. Analysts expect revenue growth to reach approximately 700 million and earnings to rise significantly, which could further drive investor confidence. This paints a positive trajectory for Oddity Tech, from its strengthened financial outlook to its targeted market positioning. Review our historical performance report to gain insights into Oddity Tech's track record. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NasdaqGM:ODD. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
01-05-2025
- Business
- Yahoo
Oddity Raises Full-year Forecast
Oddity, the parent company of Il Makiage and SpoiledChild, raised its full-year forecast as it shrugged off concerns over the economic backdrop. It now expects net revenue between $235 million and $239 million, representing year-over-year growth between 22 percent and 24 percent. Adjusted diluted earnings per share is expected between 85 cents and 89 cents. More from WWD With Less Than 10 Ingredients, Paul Mitchell's Latest Hair Care Line Is Taking on Sensitive Skin EXCLUSIVE: Tower 28 Launching Mineral Sunscreen for Sensitive and Acne-prone Skin Michelle Crossan-Matos, Ulta's Former Chief Marketer, Heads to SharkNinja 'Our Q125 results exceeded our expectations across all metrics and allow us to raise our full-year outlook. We delivered an outstanding result for our biggest quarter of the year, setting us up to overdeliver on our financial algorithm in 2025,' said Oran Holtzman, Oddity cofounder and CEO. For the first quarter, net revenue was $268 million compared to $212 million in the first quarter of 2024. Net income was $38 million, up from $33 million a year earlier. Adjusted diluted EPS were 69 cents, compared to 61 cents. 'We are pleased with our financial results for the first quarter, which beat our guidance across revenue, gross margin, adjusted [earnings before interest, taxes, depreciation and amortization], and adjusted EPS,' said Lindsay Drucker Mann, Oddity global chief financial officer. 'These excellent Q125 results, combined with a strong start to Q2, our sustained high repeat rates, the resilience of our category, and our agile business model allow us to continue investing in our growth while raising our full-year outlook.' Asked about tariffs, she called the impact 'very manageable.' 'We have some exposure, but it's really small in the scheme of things. That's why, even as we incorporated tariffs into our guidance, we actually raised our gross margin guidance for the full year from 70 to 71 percent, as well as raising our full-year EBITDA guidance. So we're in a strong position, because we already have high gross margins, which makes us just overall more insulated. We have a flexible global supply chain, and we also have a number of other efficiencies that we have already been delivering on, independent of tariffs.' Oddity is gearing up to soft-launch brand three, a telehealth platform for consumers with medical-grade skin and body issues, in the third quarter. It will be a mix of over-the-counter and prescription. Brand four will follow shortly after. Best of WWD The Best Makeup Looks in Golden Globes History A Look Back at Golden Globes Best Makeup on the Red Carpet, From Megan Fox to Sophia Loren [PHOTOS] The Best Hairstyles in Golden Globes History Sign in to access your portfolio
Daily Mail
28-04-2025
- Entertainment
- Daily Mail
I found every high-end perfume dupe at Kmart so you don't have to - and they start at just $6
Kmart fans are rushing to stores after a viral list revealed that the budget retailer's affordable perfume range includes dupes of some of the world's most popular designer scents for as little as $6. A savvy shopper shared the full list online, matching Kmart's wallet-friendly fragrances to their high-end counterparts, and shoppers are calling it a 'game changer' for beauty lovers who don't want to spend big. Fans of Daisy by Marc Jacobs ($165 for 100ml) can pick up Fresh Meadow at Kmart for just $8 - while not an exact match, it's described as a brighter, fresher take on the cult classic. Other dupes include Oddity, found in Kmart's fragrance packs, which mirrors Paradoxe by Prada but it's only available in fragrance gift packs, and Noir Night ($6 to $12) for fans of Black Opium by Yves Saint Laurent ($285). Also among the most exciting finds is In the Clouds, which retails for just $6 as a body mist and $12 as a perfume. It's said to smell almost identical to Ariana Grande 's Thank U Next - a scent that normally sells for $70 in Australia. 'From someone who owns the body mist, Cloud 1.0, 2.0, and Thank U Next, I can say In the Clouds smells almost identical to Thank U Next,' the shopper confirmed. Kmart's Royalty ($6 for a body mist) is said to be a dupe for Princess by Vera Wang ($90), although it appears to have been discontinued. Kmart has also released Hush ($12), a match for Billie Eilish's signature Eilish scent ($105). You'll also find 026 Vanilla ($8) which mimics Vanilla by Kayali ($228), and Oui ($12 in fragrance packs) for lovers of Si by Giorgio Armani ($299). So why are people opting for these bargain versions over the real thing? For many, it's about stretching their budget without sacrificing the feel-good experience of a luxurious scent. With cost-of-living pressures hitting Australians hard, a $6 perfume that smells like a $150 designer bottle is an irresistible deal. Others love the idea of being able to spritz themselves liberally throughout the day without worrying about wasting expensive fragrance. Some shoppers even stock up on the cheaper options for work, gym bags, or travel, reserving their pricey originals for special occasions. Whatever the reason, Kmart's perfume aisle is becoming the hottest spot for beauty lovers in the know - but with many of these dupes flying off the shelves, you'll have to be quick to snag one.
Irish Examiner
24-04-2025
- Entertainment
- Irish Examiner
Scary Éire: Why Irish horror films are having a moment
Steeped in the supernatural but anchored by our stories and history, Irish horror is having a moment, with tales of the unexpected and scary movies making waves at home and internationally. In a nation reared on stories of banshees and fairy forts, pookas and changelings, ghosts as well as more recent societal traumas, it makes perfect sense. Now, a new wave of talented storytellers are building on growing audience interest in our knack for bringing a scare to the screen. They include Bantry filmmaker Damian McCarthy. Following the international success of his most recent film, Oddity, McCarthy's latest drew Severance star Adam Scott to Ireland to film on location in West Cork. Hokum - shot at the recently opened West Cork Studios - stars Scott as a horror novelist who visits a remote Irish inn to spread his parents' ashes, unaware of rumours it is haunted by a witch. The film is being backed by Screen Ireland. The latest horror feature to come to our screens is in the Irish language. In cinemas from this weekend, Fréwaka tells of a young woman (Clare Monnelly) sent to a remote village to care for an agoraphobic woman Peig (Bríd Ní Neachtain). Peig lives in fear of Na Sídhe, sinister entities who she believes abducted her years before. Fréwaka's writer and director, Aislinn Clarke, believes that horror can be an interesting and unique way of looking at trauma in our lives and our histories. 'Horror is well placed to examine stuff like social trauma, generational trauma without being preachy, or worthy, or feeling like it's going to be a hard time for audiences,' says Clarke. 'Using metaphors, using the dream space to go into thinking about these things without being confronted by it too directly. Often people actually need that to start them off.' Fréwaka is the latest Irish horror film. The success of Fréwaka (meaning Roots) on the festival circuit in advance of release means that Clarke has spoken with audiences and industry people around the world - and has noticed a growing interest in Irish horror movies. 'It really is having a moment everywhere. I was in LA a few weeks ago, and everyone was talking about it like it's a phenomenon. For such a small number of people - there aren't that many of us - we're making a real impact, as we have done in other art forms as well." Clarke points out that many Irish traditional stories - the old folk tales - are very dark. "It's not really a surprise to me that we're making horrors. Historically, there wasn't that much infrastructure to allow filmmaking and new filmmakers to develop. It just wasn't there in the same way it might be in London or Hollywood,' says Clarke. As the Green Wave of Irish filmmakers and stars making their mark at home and abroad grows, it allows for more opportunity. 'It's not really surprising to me that as soon as we have that bedrock of that fertile ground, horror comes really quickly after that.' A growing number of Irish horror storytellers are bringing their spooky tales to Irish cinema audiences - but also driving strong international interest. An Taibhse (The Ghost) - made on a tiny budget by filmmaker John Farrelly and set in post-Famine Ireland - has made waves in Irish cinemas and at festivals in Brazil, Argentina and South Africa. West Cork filmmaker Damian McCarthy's Hokum is being produced by Julianne Forde and Ruth Treacy of Tailored Films. As well as their recent success with The Apprentice -the Oscar-nominated tale of the young Donald Trump - other Tailored productions include gothic horror The Lodgers. Bantry director Damian McCarthy's next film will star Severance actor Adam Scott. Picture: Marcin Lewandowski Kate Dolan's recent horror You Are Not My Mother offered an Irish perspective on a mystery around a possible changeling, while Lorcan Finnegan's NOCEBO starred Eva Green as a designer suffering from a mysterious illness. Finnegan will next direct Nicolas Cage in forthcoming thriller The Surfer. Lee Cronin's The Hole in the Ground, starring Séana Kerslake as a young mother who forms suspicions about her son, was a hit with audiences and critics. As the Irish reputation for scary movies grows, some filmmakers are drawing the interest of international studios. They include Kate Dolan, who is directing the thriller Soulm8te, to be released in cinemas worldwide next year. Some studios are also opting to make films on location in Ireland. Following his success with the latest film in the Evil Dead series, Evil Dead Rise, Irish filmmaker Lee Cronin is now shooting a new take on the iconic horror The Mummy in Ireland. Starring Jack Reynor, the film will be released internationally next year. Other big studio horrors recently filmed in Ireland include Abigail, the tale of a criminal gang who take a young girl (Irish actress Alisha Weir) to ransom, only to discover she is a vampire. Having impressed US studio bosses following the release of The Hole in the Ground, Irish writer Stephen Shields worked as co-writer on the movie, released here by Universal Pictures. That it was filmed in Ireland, he adds, was a happy coincidence. Stephen Shields wrote Abigail. 'It being shot here was just completely Kismet, just meant to be,' says Shields. 'What happened was, after Lee Cronin and I made The Hole in the Ground, I was in Los Angeles for a round of meetings. One of those meetings happened to be with Universal. I went in just to have a general conversation, had this idea for a vampire movie-heist movie in the back of my head. Universal really latched on to it.' Shields, too, feels that Irish horror filmmakers are having a moment and this is resonating internationally. 'We come from a land of fairy tales and myths, and a lot of them are very horror-centric. Now that we're growing up as filmmakers and making movies, they're coming to the forefront.' He also thinks that horror is one of the enduring staples in what is a time of ongoing change in screen entertainment. 'My personal opinion is that horror, of all the genres of filmmaking, is the most audience-friendly. And what I mean by that is, I think more people go to the cinema to watch horror because, in terms of a communal experience, it's a great genre to go and see. I put that up there with comedy as well. "It's very reactive, and that's not to say anything bad about dramas or anything like that, but I think people like to go to the cinema to have that emotional experience." Shields adds that you don't need a really big-name star to sell a good horror film. "It's always good when you have a big movie star - but I think the concept of horror itself is the thing people go to the cinema to see. It's the experience that sells. It serves as a great genre for attracting up and coming stars as well, which is always good. A lot of the most famous Hollywood movie stars out there started their journey in the horror space.' Fréwaka is in cinemas as from Friday, April 25. is in cinemas as from Friday, April 25. Abigail is on rental platforms including Sky and Apple TV
